Clinical trials

  • SOTORASIB for Non-small cell lung cancer (KRAS p.G12C-mutated)
  • D,L-lysine acetylsalicylate for Aortic stenosis
  • Avutometinib for Low-grade serous ovarian cancer | Recurrent low-grade serous ovarian cancer
  • Atezolizumab for Hepatocellular carcinoma
  • TAFASITAMAB for Follicular lymphoma
  • RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NHBA FUSION PROTEIN; RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NADA PROTEIN; RECOMBINANT NEISSERIA MENINGITIDIS GROUP B FHBP FUSION PROTEIN; OUTER MEMBRANE VESICLES (OMV) FROM NEISSERIA MENINGITIDIS GROUP B STRAIN NZ98/254 (measured as amount of total protein containing the PorA P1.4) (all adsorbed on aluminium hydroxide) for Asplenia
  • Clinical trial in Human immunodeficiency virus (HIV) infection
  • Melphalan for Uveal melanoma | Liver metastases
  • Human alpha-1-proteinase inhibitor immunoglobulin G fusion protein, recombinant for Alpha-1 antitrypsin deficiency (AATD) | Emphysema
  • METHYLPREDNISOLONE HYDROGEN SUCCINATE for Neuroendocrine cell hyperplasia of infancy
  • [177Lu]Lu-AKIR001 for Anaplastic thyroid cancer | Thyroid cancer stage IV | Squamous cell carcinoma of head and neck | Squamous cell carcinoma of the cervix | Squamous cell carcinoma of the vulva | Non-small cell lung cancer
  • ESKETAMINE for Bipolar disorder, depressive episode